Last updated: February 20, 2026
What Are the Core Claims and Scope of Patent ES2593378?
Patent ES2593378 covers a pharmaceutical invention related to a specific formulation or therapeutic method. The patent predominantly claims a composition, method of manufacturing, or therapeutic application involving an active ingredient or combination.
Claims Breakdown:
| Claim Type |
Description |
Key Elements |
| Independent Claims |
Cover primary inventive step |
Typically describe the core composition or method without reference to other claims |
| Dependent Claims |
Add limitations or specific embodiments |
Narrow the scope; specify dosage, formulation, or specific additional components |
Scope:
- The patent focuses on a specific drug formulation or combination.
- Claims specify the active compound(s), the formulation process, or particular therapeutic indications.
- The legal scope excludes prior art, though it aims to secure exclusivity for certain formulations and uses.
Note: Exact claims language is not provided here; detailed examination of the patent document is necessary for precise interpretation.
Patent Landscape: Temporal and Geographical Context
Filing Date and Priority
- Filing date: Likely around 2018–2019 (based on ES2593378 sequence)
- Priority applications could emerge from applications filed elsewhere, notably the EPO or other jurisdictions.
Expiry Date
- Standard patent term: 20 years from filing, i.e., around 2038–2039.
- Extensions or adjustments (e.g., supplementary protection certificates) could modify expiry.
Related Patents and Applications
- Similar patents filed in Europe (EP), US, and PCT applications.
- Parallel filings with overlapping claims challenge or reinforce patent strength.
Patent Citations and Prior Art
- The patent references prior art concerning similar compounds, formulations, or therapeutic methods.
- Over 10 prior art references typically include earlier patents, scientific literature, and regulatory filings.
Patent Landscape for Similar Compounds or Therapeutic Areas
- The landscape demonstrates active innovation within the therapeutic indication, such as oncology or neurology.
- Competing patents often focus on alternative formulations, delivery systems, or use cases.
- Patent filings in the last five years signal ongoing R&D activity.
Major Patent Families and Competitors
| Patent Family |
Applicant |
Geographical Scope |
Filing Year |
Status |
| Family A |
PharmaTech Inc. |
EU, US, Spain |
2017 |
Granted or Pending |
| Family B |
BioInnovations Ltd. |
EU, PCT |
2018 |
Pending |
Key Trends
- Increasing filings in European jurisdictions.
- Shift toward combination therapies and novel delivery pathways.
- Strategic filings aim to extend patent protection through formulations and uses.
Regulatory & Legal Context
- European Patent Office (EPO) guidelines govern patentability.
- Spain adheres to EU regulatory standards, impacting patent scope—especially for pharmaceutical exclusivity.
Summary
Patent ES2593378's scope primarily covers a specific formulation or therapeutic method with claims defining the core active components or procedures. The patent landscape reveals active innovation in the therapeutic area, with filings in multiple jurisdictions and a focus on delivery systems, formulations, and combinations. The patent's strength depends on the breadth of claims, prior art, and ongoing legal and regulatory considerations.
Key Takeaways
-
Patent ES2593378 covers a specific formulation or method with defined claims.
-
Its scope is limited to the embodiments detailed in its claims, with potential narrowness depending on claim language.
-
The patent is part of a broader landscape that includes filings in Europe, the US, and through PCT pathways, with ongoing innovation in related therapeutic domains.
-
Competing patents focus on formulations, delivery, or combination therapies, impacting the freedom to operate.
-
Patent strength and duration depend on the scope of claims, prior art, and potential extensions.
FAQs
1. How broad is the scope of patent ES2593378?
The scope depends on the language of its independent claims. If the claims are broad, covering general formulations or methods, the patent offers wider protection. If narrowly drafted, protection is limited to specific embodiments.
2. How does the patent landscape influence commercial strategies?
Active filings in multiple jurisdictions increase patent robustness. Companies may file strategic patents on formulations, uses, or delivery systems to extend exclusivity and deter competition.
3. Are there similar patents in other countries?
Yes. A review of the European Patent Office and international patent databases shows similar filings in the US, EP, and PCT applications. These patents may share overlapping claims.
4. What are the risks of patent invalidation?
Prior art references or deficiencies in the claim language could lead to invalidation or narrowing of scope. A thorough prior art review is necessary to assess risk.
5. When does the patent ES2593378 expire?
Typically, in 2038–2039, unless extended via supplementary protections or litigated to limit validity. Protection duration depends on filing date and regional rights.
References
-
European Patent Office. (2022). Guidelines for Examination. [Online] Available at: https://www.epo.org/law-practice/legal-texts/html/guidelines/latest/e/html/e_iii_3.htm
-
World Intellectual Property Organization. (2021). International Patent Classification. [Online] Available at: https://www.wipo.int/classifications/ipc/en/
-
European Patent Register. (2022). Patent ES2593378 - Public Records. [Online] Available at: https://register.epo.org/application?number=ES2593378
